Clinical Trial Update: Adjunctive Cannabidiol for Recovery From Opioid Study [Phase 3]

View source ↗

Summary

This update notes a Phase 3 trial evaluating adjunctive cannabidiol for recovery in opioid use disorder is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• Cannabidiol (cannabidiol)

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Opioid Use Disorder (OUD) | Phase 3 | Status: RECRUITING